[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100496082":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":18,"responsibleParty":50,"collaborators":7,"id":52,"slug":7,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":53,"sex":59,"minAge":60,"maxAge":7,"enrollmentInfo":61,"targetDuration":64,"studyType":65,"phases":7,"briefSummary":66,"conditions":67,"keywords":69,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"GBG Forschungs GmbH","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Sibylle Loibl, Prof. Dr.","STUDY_CHAIR",[13],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Thomas Ballhausen, Dr.","CONTACT","0049610274800","eternity@gbg.de",[19,32,41],{"facility":20,"status":21,"city":22,"state":7,"zip":23,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":7},"MUI - Univ. Klinik f. Frauenheilkunde Innsbruck","RECRUITING","Innsbruck","6020","Austria","AT",{"type":27,"coordinates":28},"Point",[29,30],11.39454,47.26266,{"lat":30,"lon":29},{"facility":33,"status":21,"city":34,"state":7,"zip":35,"country":24,"countryCode":25,"cosmosGeoPoint":36,"geoPoint":40,"contacts":7},"Ordensklinikum Linz GmbH - BHS","Linz","4020",{"type":27,"coordinates":37},[38,39],14.28611,48.30639,{"lat":39,"lon":38},{"facility":42,"status":21,"city":43,"state":7,"zip":44,"country":24,"countryCode":25,"cosmosGeoPoint":45,"geoPoint":49,"contacts":7},"LKH Salzburg - PMU","Salzburg","5020",{"type":27,"coordinates":46},[47,48],13.04399,47.79941,{"lat":48,"lon":47},{"type":51,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100496082",false,"NCT05739591","Long-term Safety and Efficacy of GBG Study Participants","Registry for Long-term Follow-up of Safety and Efficacy Parameters of GBG Study Participants","ETERNITY","Inclusion criteria:\n\n* Participation and treatment in a GBG clinical trial for early breast cancer.\n* Prospective registration: Written informed consent according to local regulatory requirements prior to data and biomaterial collection.\n\nExclusion criteria:\n\n* Participation and treatment in a non-GBG clinical trial for early breast cancer.\n* Patients with advanced or metastatic breast cancer who have participated and received treatment in a GBG clinical trial.","ALL","18 Years",{"count":62,"type":63},400,"ESTIMATED","10 Years","OBSERVATIONAL","The ETERNITY study is an international, multicenter, observational study that aims to follow up patients who have participated in a GBG trial for early breast cancer, even after the study has officially ended, in order to collect long-term data on survival, late or delayed adverse events, in addition to information related to pregnancy, fertility and other parameters impacting quality of life.",[68],"Breast Cancer",[70,71,72,73,74,75,76],"Registry","Breast cancer, early","Safety","Efficacy","Long-term follow-up","Long-term survival","German Breast Group","2024-10-01",{"date":79,"type":80},"2024-10-02","ACTUAL",{"date":82,"type":80},"2022-10-12",{"date":84,"type":63},"2030-05-19",{"name":5,"class":6},3]